Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism

Phase 1

• Conditions: Hyperparathyroidism
• Interventions: Radiation: Far Infrared Radiation

• Registration Number: NCT00573573
• Lead Sponsor: GAAD Medical Research Institute Inc.

Brief Summary

A study to determine the possibility of using far infrared radiation to treat Hyperparathyroidism.

Detailed Description

Overactive parathyroid glands secrete an excess of parathyroid hormones, resulting in increased levels of calcium in the blood stream, which can lead to weakening of the bones and to kidney stones.

We are postulating that the non-invasive energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to stop the over secretion of the parathyroid hormones and normalize the body's metabolic functions.

Study Timeline

• Study Start: 2007-01
• Study First Submitted: 2007-12-12
• Study First Submitted QC: 2007-12-12
• Study First Posted: 2007-12-14
• Status Verified: 2009-03
• Primary Completion: 2009-03
• Last Update Submitted: 2009-03-23
• Last Update Posted: 2009-03-24
• Study Completion: 2009-07

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2

Inclusion Criteria

• Persons with parathyroid disease

Exclusion Criteria

• None

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Far Infrared Radiation	-

Primary Outcome Measures

Name	Time	Method
The primary end point is to determine the therapeutic effects of far infrared radiation on Hyperparathyroidism.	2 years

Secondary Outcome Measures

Name	Time	Method
Effect of far infrared radiation treatment on other immune deficiency diseases like thyroidism and diabetes	2 years

Trial Locations

Locations (1)

The Centre for Incurable Diseases; 🇨🇦 Toronto, Ontario, Canada